Peak Pharmaceuticals (OTCMKTS:PKPH) Stock Price Down 0.6% – Should You Sell?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report) shares dropped 0.6% during mid-day trading on Wednesday . The stock traded as low as $0.8548 and last traded at $0.8548. 101 shares changed hands during trading, a decline of 99% from the average daily volume of 9,053 shares. The stock had previously closed at $0.8603.

Peak Pharmaceuticals Price Performance

The stock’s fifty day moving average is $1.00 and its two-hundred day moving average is $1.66.

About Peak Pharmaceuticals

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Read More

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.